Filters
Use basic filters below or open advanced options for more precise results.
Last dataset refresh: 25 Sep 2026
| Product name | Classification | Strength | Form | Manufacturer | Country of origin | Status | Registered On | Action | |
|---|---|---|---|---|---|---|---|---|---|
|
Retevmo™ 80 mg
|
Conventional Medicines | 80 mg / capsule | Capsule | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 22 Oct 2020 | View details → | |
|
Retevmo™ 80 mg
|
Conventional Medicines | 80 mg / capsule | Capsule | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 22 Oct 2020 | View details → | |
|
Retevmo™ 80mg
|
Conventional Medicines | 80 mg/Tablets | Tablet | ELI LILLY AND COMPANY , United States of America, Indianapolis | United States of America | Active | 30 Sep 2025 | View details → | |
|
Retinac Gel 0.1%
|
Conventional Medicines | 0.1 % w/w | Gel | Vieco Pharmaceuticals FZCO, United Arab Emirates, Dubai | United Arab Emirates | Active | 15 Aug 2025 | View details → | |
|
RetoMed Eye Ointment
|
Medical Devices for Humans | 25,000 I.U/100 g | Ointment | FARMIGEA SpA.., Italy, Pisa | United Arab Emirates | Active | 09 Apr 2026 | View details → | |
|
RETROVIR
|
Conventional Medicines | 10mg/ml | Solution | BORA PHARMACEUTICAL SERVICES INC, Canada, Mississauga | United Kingdom | Active | 20 Mar 1993 | View details → | |
|
RETROVIR
|
Conventional Medicines | 10mg/ml | Solution | BORA PHARMACEUTICAL SERVICES INC, Canada, Mississauga | United Kingdom | Active | 20 Mar 1993 | View details → | |
|
REVANESSE® CONTOUR™ + With Lidocaine
|
Medical Devices for Humans | Device | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® KISS™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® OUTLINE™ +
|
Medical Devices for Humans | combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2022 | View details → | |
|
REVANESSE® PURE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® REVISE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
REVANESSE® SHAPE™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
Revanesse® Ultra
|
Medical Devices for Humans | 25 mg/ml | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 29 Sep 2011 | View details → | |
|
REVANESSE® ULTRA™ + With Lidocaine
|
Medical Devices for Humans | Combination | Injection | PROLLENIUM MEDICAL TECHNOLOGIES INC. , Canada, Ontario | Canada | Active | 15 Mar 2024 | View details → | |
|
Revardia® 6 mg per 2 mL
|
Conventional Medicines | 3 mg/ml | Injection | Tabuk Pharmaceutical Manufacturing Co, Saudi Arabia, Dammam | Saudi Arabia | Active | 18 Jan 2024 | View details → | |
|
Revcox 200 mg
|
Conventional Medicines | 200 mg/capsule | Capsule | LEK PHARMACEUTICALS d.d., Slovenia, Lendava | Switzerland | Active | 29 Nov 2015 | View details → | |
|
Revcox 200 mg
|
Conventional Medicines | 200 mg/capsule | Capsule | LEK PHARMACEUTICALS d.d., Slovenia, Lendava | Switzerland | Active | 29 Nov 2015 | View details → | |
|
REVERSION GEL
|
Medical Devices for Humans | 5mg (0.1%) | Gel | PalCare Enterprises Inc., Canada, Richmond | Canada | Active | 04 May 2023 | View details → | |
|
Revestive® 1.25 mg
|
Biological Medicines | 1.25mg/Vial | Injection | Takeda Pharmaceuticals International AG Ireland Branch, Ireland, Dublin 2 | Ireland | Active | 18 Feb 2026 | View details → | |
|
Revestive® 5 mg
|
Biological Medicines | 5mg/Vial | Injection | Takeda Pharmaceuticals International AG Ireland Branch, Ireland, Dublin 2 | Ireland | Active | 18 Feb 2026 | View details → | |
|
Reviscon 1.0%
|
Medical Devices for Humans | 1.0% | Injection | VSY Biyoteknoloji ve İlaç Sanayi A.Ş., Turkey, İstanbul | Germany | Active | 24 Aug 2022 | View details → | |
|
Reviscon Mono 2.0%
|
Medical Devices for Humans | 2.0% | Injection | VSY Biyoteknoloji ve İlaç Sanayi A.Ş., Turkey, İstanbul | Germany | Active | 24 Aug 2022 | View details → | |
|
Reviscon Plus 1.6%
|
Medical Devices for Humans | 1.6% | Injection | VSY Biyoteknoloji ve İlaç Sanayi A.Ş., Turkey, İstanbul | Germany | Active | 24 Aug 2022 | View details → |
Compare selected products
0 of 3 selected